Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 4, 2009, Pages 301-311

  Maher, Sam ^a   Wang, Xuexuan ^a   Bzik, Victoria ^a   McClean, Siobhan ^b   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Absorption promotion; Epithelial transport; Melittin; Oral macromolecule delivery; Sodium caprate

Indexed keywords

CARBON 14; DECANOATE SODIUM; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MANNITOL; MELITTIN; PENETRATION ENHANCING AGENT; SODIUM DERIVATIVE; SUGAR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CELL DAMAGE; COLON; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG INFUSION; DRUG INSTILLATION; DRUG SCREENING; ELECTRON MICROSCOPY; HISTOPATHOLOGY; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; INTESTINE MUCOSA; JEJUNUM; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COLON; DECANOIC ACIDS; INSTILLATION, DRUG; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MALE; MELITTEN; PERFUSION; RATS; RATS, WISTAR;

EID: 70349838243     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.07.011     Document Type: Article

References (81)

1. Ambati J., Canakis C.S., Miller J.W., Gragoudas E.S., Edwards A., Weissgold D.J., Kim I., Delori F.C., and Adamis A.P. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1181-1185
2. Anderberg E.K., Lindmark T., and Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10 (1993) 857-864
3. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000) 429-442
4. Blikslager A.T., Moeser A.J., Gookin J.L., Jones S.L., and Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol. Rev. 87 (2007) 545-564
5. Brayden D., Creed E., O'Connell A., Leipold H., Agarwal R., and Leone-Bay A. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm. Res. 14 (1997) 1772-1779
6. Chao A.C., Nguyen J.V., Broughall M., Griffin A., Fix J.A., and Daddona P.E. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int. J. Pharm. 191 (1999) 15-24
7. Curatolo W., and Ochoa R. Safety assessment of intestinal permeability enhancers. In: De Boer A.G. (Ed). Drug Absorption Enhancement Concepts, Possibilities, Limitations and Trends (1994), Harwood Academic Publishers 155-175
8. Dos Santos I., Fawaz F., Lagueny A.M., and Bonini F. Improvement of norfloxacin oral bioavailability by EDTA and sodium caprate. Int. J. Pharm. 260 (2003) 1-4
9. Esposito C., Colicchio P., Facchiano A., and Ragone R. Effect of a weak electrolyte on the critical micellar concentration of sodium dodecyl sulfate. J. Colloid Interface Sci. 200 (1998) 310-312
10. Fasano A., and Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. 99 (1997) 1158-1164
11. Feighery L.M., Cochrane S.W., Quinn T., Baird A.W., O'Toole D., Owens S.E., O'Donoghue D., Mrsny R.J., and Brayden D.J. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. Pharm. Res. 25 (2008) 1377-1386
12. Fetih G., Lindberg S., Itoh K., Okada N., Fujita T., Habib F., Artersson P., Attia M., and Yamamoto A. Improvement of absorption enhancing effects of n-dodecyl-beta-d-maltopyranoside by its colon-specific delivery using chitosan capsules. Int. J. Pharm. 293 (2005) 127-135
13. Gazzaniga A., Maroni A., Sangalli M.E., and Zema L. Time-controlled oral delivery systems for colon targeting. Expert Opin. Drug Deliv. 3 (2006) 583-597
14. Geary R., Yu R., Kim T.-W., Levin A., Dokka S., Tillman L.G., and Hardee G. Pharmacokinetics and tolerability of daily oral antisense oligonucleotide, ISIS 301012 in mice and dogs for 13 weeks. AAPS J. 7 (2005) S2
15. Hardee G., Geary R., Tillman L.G., Bradley J., Su J., Dokka S., and Wedel M. A phase I study of orally administered ISIS 301012 for the reduction of ApoB-100 and LDL-cholesterol. AAPS J. 8 (2006) S1
16. Haupt S., and Rubinstein A. The colon as a possible target for orally administered peptide and protein drugs. Crit. Rev. Ther. Drug Carrier Syst. 19 (2002) 499-551
17. Higaki K., Yata T., Sone M., Ogawara K., and Kimura T. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine. Res. Commun. Mol. Pathol. Pharmacol. 109 (2001) 231-240
18. Hughes B. 2008 FDA drug approvals. Nat. Rev. Drug Discov. 8 (2009) 93-96
19. Imai T., Sakai M., Ohtake H., Azuma H., and Otagiri M. Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid. Int. J. Pharm. 294 (2005) 11-21
20. Ishizawa T., Hayashi M., and Awazu S. Enhancement of jejunal and colonic absorption of fosfomycin by promoters in the rat. J. Pharm. Pharmacol. 39 (1987) 892-895
21. Jones M.N. Surfactants in membrane solubilisation. Int. J. Pharm. 177 (1999) 137-159
22. Kinouchi Y., Takeichi Y., and Yata N. A novel method for the preclinical assessment of rectal irritation. J. Pharm. Pharmacol. 48 (1996) 310-315
23. Komiya I., Park J.Y., Kamani A., Ho N.F.H., and Higuchi W.I. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 4 (1980) 249-262
24. Kondoh M., Masuyama A., Takahashi A., Asano N., Mizuguchi H., Koizumi N., Fujii M., Hayakawa T., Horiguchi Y., and Watanbe Y. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol. Pharmacol. 67 (2005) 749-756
25. Kondoh M., Takahashi A., Fujii M., Yagi K., and Watanabe Y. A novel strategy for a drug delivery system using a claudin modulator. Biol. Pharm. Bull. 29 (2006) 1783-1789
26. Lee V.H., Yamamoto A., and Kompella U.B. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Syst. 8 (1991) 91-192
27. Lennernas H., Gjellan K., Hallgren R., and Graffner C. The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans. J. Pharm. Pharmacol. 54 (2002) 499-508
28. Leonard T.W., Lynch J., McKenna M.J., and Brayden D.J. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET. Expert Opin. Drug Deliv. 3 (2006) 685-962
29. Lindmark T., Kimura Y., and Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J. Pharmacol. Exp. Ther. 284 (1998) 362-369
30. Lindmark T., Söderholm J.D., Olaison G., Alván G., Ocklind G., and Artursson P. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm. Res. 14 (1997) 930-935
31. Ma T.Y., Hollander D., Erickson R.A., Truong H., Nguyen H., and Krugliak P. Mechanism of colonic permeation of inulin: is rat colon more permeable than small intestine?. Gastroenterology 108 (1995) 12-20
32. Maher S., Feighery L., Brayden D.J., and McClean S. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers. Pharm. Res. 24 (2007) 1336-1345
33. Maher S., Feighery L., Brayden D.J., and McClean S. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae. Pharm. Res. 24 (2007) 1346-1356
34. Maher, S., Kennelly, R., Bzik, V., Baird, A.W., Wang, X., Winter, D., Brayden, D.J., 2009. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in Isolated rat and human colonic mucosae. Eur. J. Pharm. Sci., in press.
35. Maher S., and McClean S. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 71 (2006) 1289-1298
36. Maher S., and McClean S. Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol. Biochem. Pharmacol. 75 (2008) 1104-1114
37. Masuda K., Ikeda H., Kasai K., Fukuzawa Y., Nishimaki H., Takeo T., and Itoh G. Diversity of restitution after deoxycholic acid-induced small intestinal mucosal injury in the rat. Dig. Dis. Sci. 48 (2003) 2108-2115
38. Miyake M., Minami T., Oka Y., Kamada N., Yamazaki H., Kato Y., Mukai T., Toguchi H., Odomi M., Ogawara K., Higaki K., and Kimura T. Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide. Biol. Pharm. Bull. 29 (2006) 330-335
39. Miyake M., Oka Y., Minami T., Toguchi H., Odomi M., Ogawara K., Higaki K., and Kimura T. Combinatorial use of sodium laurate with taurine or l-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. J. Pharm. Sci. 92 (2003) 911-921
40. Mizuno A., Ueda M., and Kawanishi G. Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats. J. Pharm. Pharmacol. 44 (1992) 570-573
41. Moore R., Carlson S., and Madara J.L. Villus contraction aids repair of intestinal epithelium after injury. Am. J. Physiol. 257 (1989) G274-G283
42. Morigaki K., Walde P., Misran M., and Robinson B.H. Thermodynamic and kinetic stability. Properties of micelles and vesicles formed by the decanoic acid/decanoate system. Colloids Surf. A: Phys. Eng. Aspects 213 (2003) 37-44
43. Morimoto Y., Mutoh M., Ueda H., Fang L., Hirayama K., Atobe M., and Kobayashi D. Elucidation of the transport pathway in hairless rat skin enhanced by low-frequency sonophoresis based on the solute-water transport relationship and confocal microscopy. J. Control. Release 103 (2005) 587-597
44. 2EDTA and sodium glycocholate on intestinal absorption of insulin. Biol. Pharm. Bull. 16 (1993) 68-72
45. Motlekar N.A., Srivenugopal K.S., Wachtel M.S., and Youan B.B. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels. J. Drug Target. 13 (2005) 573-583
46. Mrsny R.J. The colon as a site for drug delivery. J. Control. Release 22 (1992) 15-34
47. Mrsny R.J. Modification of epithelial tight junction integrity to enhance transmucosal absorption. Crit. Rev. Ther. Drug Carrier Syst. 22 (2005) 331-418
48. Narkar Y., Burnette R., Bleher R., Albrecht R., Kandela A., and Robinson J.R. Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer. Pharm. Res. 25 (2008) 25-38
49. Navia M.A., and Chaturvedi P.R. Design principles for orally bioavailable drugs. Drug Discov. Today 1 (1996) 179-189
50. Nishimura K., Nozaki Y., Yoshimi A., Nakamura S., Kitagawa M., Kakeya N., and Kitao K. Studies on the promoting effects of carboxylic acid derivatives on the rectal absorption of beta-lactam antibiotics in rats. Chem. Pharm. Bull. 33 (1985) 282-291
51. Numata N., Takahashi K., Mizuno N., Utoguchi N., Watanabe Y., Matsumoto M., and Mayumi T. Improvement of intestinal absorption of macromolecules by nitric oxide donor. J. Pharm. Sci. 89 (2000) 1296-1304
52. Raghuraman H., and Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci. Rep. 27 (2007) 189-223
53. Raoof A.A., Chiu P., Ramtoola Z., Cumming I.K., Teng C., Weinbach S.P., Hardee G.E., Levin A.A., and Geary R.S. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J. Pharm. Sci. 93 (2004) 1431-1439
54. Raoof A.A., Ramtoola Z., McKenna B., Yu R.Z., Hardee G., and Geary R.S. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur. J. Pharm. Sci. 17 (2002) 131-138
55. Schiller C., Frohlich C.P., Giessmann T., Siegmund W., Monnikes H., Hosten N., and Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 22 10 (2005) 971-979
56. Sharma P., Varma M.V., Chawla H.P., and Panchagnula R. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Farmaco 60 (2005) 884-893
57. Sharma P., Varma M.V., Chawla H.P., and Panchagnula R. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco 60 (2005) 874-883
58. Shima M., Yohdoh K., Yamaguchi M., Kimura Y., Adachi S., and Matsuno R. Effects of medium-chain fatty acids and their acylglycerols on the transport of penicillin V across Caco-2 cell monolayers. Biosci. Biotechnol. Biochem. 61 (1997) 1150-1155
59. Steiner R.F., Marshall L., and Needleman D. The interaction of melittin with calmodulin and its tryptic fragments. Arch. Biochem. Biophys. 246 (1986) 286-300
60. Sugita Y., Takao K., Toyama Y., and Shirahata A. Enhancement of intestinal absorption of macromolecules by spermine in rats. Amino Acids 33 (2007) 253-260
61. 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS PharmSci 3 (2001) E25
62. Swenson E., and Curatolo W.J. Means to enhance penetration. (2) Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 8 (1992) 39-92
63. Takahashi H., Shibasaki T., Takeshita K., Kaiho F., and Hayashi M. The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway. Biol. Pharm. Bull. 20 (1997) 446-448
64. Takahashi K., Murakami T., Kamata A., Yumoto R., Higashi Y., and Yata N. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats. Pharm. Res. 11 (1994) 388-392
65. Takahashi K., Murakami T., Yumoto R., Hattori T., Higashi Y., and Yata N. Decanoic acid induced enhancement of rectal absorption of hydrophilic compounds in rats. Pharm. Res. 11 10 (1994) 1401-1404
66. Takeichi Y., Baba K., Kinouchi Y., Iida Y., Umeno Y., Muranishi S., and Nakai Y. Combinative improving effect of increased solubility and the use of absorption enhancers on the rectal absorption of uracil in beagle dogs. Chem. Pharm. Bull. 38 (1990) 2547-2551
67. Tillman L.G., Geary R.S., and Hardee G.E. Oral delivery of antisense oligonucleotides in man. J. Pharm. Sci. 97 (2008) 225-236
68. Tomita M., Hayashi M., Horie T., Ishizawa T., and Awazu S. Enhancement of colonic drug absorption by the transcellular permeation route. Pharm. Res. 5 (1988) 786-789
69. Tomita M., Shiga M., Hayashi M., and Awazu S. Enhancement of colonic drug absorption by the paracellular permeation route. Pharm. Res. 5 (1988) 341-346
70. Tosteson M.T., Holmes S.J., Razin M., and Tosteson D.C. Melittin lysis of red cells. J. Membr. Biol. 87 (1985) 35-44
71. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2 (2001) 285-293
72. Van den Mooter G. Colon drug delivery. Expert Opin. Drug Deliv. 3 (2006) 111-125
73. van Hoogdalem E., de Boer A.G., and Breimer D.D. Pharmacokinetics of rectal drug administration. Part I. General considerations and clinical applications of centrally acting drugs. Clin. Pharmacokinet. 21 (1991) 11-26
74. van Hoogdalem E.J., Hardens M.A., de Boer A.G., and Breimer D.D. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: concentration-effect relationship. Pharm. Res. 5 (1988) 453-456
75. Waller D.A., Thomas N.W., and Self T.J. Restitution in the large intestine of the rat following insult with bile salts. Virchows Arch. A. Pathol. Anat. Histopathol. 414 (1988) 77-81
76. Walsh G. Market Development of Biopharmaceuticals. Genetic Engineering in Livestock: New Applications and Interdisciplinary Perspectives vol. 34 (2009) 69-89
77. Ward P.D., Tippin T.K., and Thakker D.R. Epithelial enhancing paracellular permeability by modulating epithelial tight junctions. Pharm. Sci. Technol. Today 3 (2000) 346-358
78. Watanabe Y. Permeation pathways in rectal absorption. In: Touitou E., and Barry B.W. (Eds). Enhancement in Drug Delivery (2006), CRC Press 135-146
79. Whitehead K., Karr N., and Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm. Res. 25 (2008) 1782-1788
80. Woodley J.F. Enzymatic barriers for GI peptide and protein delivery. Crit. Rev. Ther. Drug Carrier Syst. 11 (1994) 61-95
81. Yamamoto A., Uchiyama T., Nishikawa R., Fujita T., and Muranishi S. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J. Pharm. Pharmacol. 48 (1996) 1285-1289